Evidence map›Paper›PMID 23604566›Full record

ArticleParasitology research2013

In vitro control of the camel nasal botfly, Cephalopina titillator, with doramectin, lavender, camphor, and onion oils.

Hanem F Khater, Mohamed Y Ramadan, Abla D Abdel Mageid

Abstract read
PubMed Publisher
In one paragraph

Article in Parasitology research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it, 39 citations in OpenAlex.

  1. Global epidemiology ofFrontiers in veterinary science · 2026
    Pooled it
  2. Review
  3. Morphological and genetic demonstration ofOpen veterinary journal · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Novel Pesticidal Efficacy ofPlants (Basel, Switzerland) · 2022
    Article
  10. Review
  11. Efficacy of some essential oils onJournal of parasitic diseases : official organ of the Indian Society for Parasitology · 2018
    Article
  12. Larvicidal activity of camphor and lavender oils against sheep blowfly,Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2016
    Article
  13. Article
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Hanem F KhaterDepartment of Parasitology, Faculty of Veterinary Medicine, Benha University, Moshtohor, Toukh 13736, Egypt. hafkhater@yahoo.com
Mohamed Y Ramadan
Abla D Abdel Mageid
Benha University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Camels are very important livestock particularly in arid and semiarid lands. The oestrid fly, Cephalopina titillator (Clark), causes nasopharyngeal myiasis in camels, and it is widely distributed in many camel breeding areas triggering health hazards and severe economic losses in camels. The prevalence of infestation of camels (slaughtered at Tokh's slaughterhouse, Qalyubia Governorate, Egypt, during the period from September 2011 to March 2012) was 41.67 % (100 out of 240). Most infested camels developed clinical signs of nasal discharge, restlessness, loss of appetite, difficulty in breathing, frequent sneezing, and snoring. Postmortem examination of infested camels explained that breathing of the animal is greatly impaired because of blockage of the nasopharynx by larvae and/or mucofibrinous secretions. The larval count per camel ranged from 1 to 250 (mean 28.45 ± 6.48). In vitro larval immersion tests were carried out to determine the efficacy of doramectin (0.003 %) as well as some essential oils (50 % each) such as lavender, camphor, and onion oils against the second and third larval stages (L2 and L3) of C. titillator. Another trial had been done for imitating what could happen if the area around camels were treated with an insecticide or an insect repellent. All treated L2 died 18 h posttreatment (PT) with both doramectin and lavender, and 100 % mortality was reached for L3 after 24 and 30 h PT with lavender and doramectin, respectively. Doramectin and lavender induced the highest response against C. titillator as their lethal time (LT50) values after treatment of L2 were 3.40 and 3.60 h, respectively, and those of L3 were 4.99 and 5.53 h, respectively. Against both L2 and L3 of C. titillator and based on LT50 values of onion oil and those of other applied materials, doramectin and lavender oil were four times more effective than onion oil, and camphor oil was two times more effective than onion oil. Based on LT50 values of essential oils and those of doramectin, as a reference substance, the relative speed of efficacy indicated that camphor and onion oils were, respectively, two and four times less effective than doramectin and lavender. With regard to fumigant technique, neither the insecticide, New Pyrosol, nor the insect repellent, Keto, was effective in controlling C. titillator larvae. Our results indicated that doramectin and lavender could be selected as drugs of choice for controlling C. titillator, but it is not permitted to use doramectin on dairy animals during lactation. Lavender (50 %) has a great potential to be developed as a novel larvicide and could be used as nasal drench against nasal botfly which will reflect on camel production and the national economy.

Indexed as

AnimalsBiological AssayCamelusDipteraEgyptInsecticidesInsect RepellentsIvermectinLarvaMyiasisNasal CavityOils, VolatileParasite LoadSurvival AnalysisdoramectinInsecticidesInsect RepellentsIvermectinOils, Volatile

Identifiers

PMID23604566
OpenAlexW2086008696

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.